Mahesh Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 73 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -3.13%
- Profit Growth -50.76%
- Ebitda -345.63%
- Net Worth 434.06%
- Total Assets -1.47%
About Mahesh Laboratories
Mahesh Laboratories Pvt Ltd (MLPL) was founded in India on 10 December 1951 and has a glorious history of 73 years and two months.Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anupam Bhattacharyya and Ratna Bhattacharyya serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24223WB1951PTC020147
- Company No.
020147
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 1951
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Mahesh Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anupam Bhattacharyya  | Managing Director | 10-May-1973 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ratna Bhattacharyya | Director | 18-May-1983 | Current |
Financial Performance of Mahesh Laboratories.
Mahesh Laboratories Pvt Ltd, for the financial year ended 2022, experienced Minor drop in revenue, with a 3.13% decrease. The company also saw a substantial fall in profitability, with a 50.76% decrease in profit. The company's net worth Soared by an impressive increase of 434.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mahesh Laboratories?
In 2019, Mahesh Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
M Bhattacharyya Homoeopathic Pvt LtdAnupam Bhattacharyya and Ratna Bhattacharyya are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mahesh Laboratories?
Mahesh Laboratories has a workforce of 9 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahesh Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahesh Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.